Intensity Therapeutics, Inc. 公布其二期术前三阴性乳腺癌Invincible-4研究最新进展

美股速递
Yesterday

Intensity Therapeutics, Inc. 近期发布了关于其正在进行的二期临床试验——Invincible-4研究的最新信息。该研究主要针对术前三阴性乳腺癌患者,旨在评估新型疗法的安全性与有效性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10